Bioavailability of Telmisartan/Amlodipine Fixed-dose Combination Compared to Its Mono-components in Healthy Male Volunteers

NCT02259790 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Telmisartan/amlodipine fixed-dose combination tablet
DRUG: Telmisartan
DRUG: Amlodipine

Sponsor

Boehringer Ingelheim